Log In
Print
BCIQ
Print
Print this Print this
 

Tetrabik

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSubcutaneous vaccine comprises Bordetella pertussis, diphtheria toxoid, tetanus toxoid and inactivated Savin types 1, 2 and 3 of polio virus
Molecular Target
Mechanism of ActionVaccine
Latest Stage of DevelopmentMarketed
IndicationInfectious
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today